Latest News about acute myeloid leukemia
Recent news which mentions acute myeloid leukemia
   Cancer Drug Trials Put On Hold After Patients Died
   
  
  
  June 17, 2023
  From Benzinga
 
   Moleculin Biotech Annamycin Doublet Therapy Shows 68% Overall Survival In Animal Study
   
  February 14, 2022
  Tickers 
   MBRX
  
  
  From Benzinga
 
   FDA Lifts Partial Hold On Kura Oncology's Early-Stage Leukemia Trial
   
  January 21, 2022
  Tickers 
   KURA
  
  
  From Benzinga
 
   Aptose Shares Fall After HM43239 Data Featured At ASH Annual Meeting, Luxeptinib, APTO-253 Update
   
  December 14, 2021
  Tickers 
   APTO
  
  
  From Benzinga
 
   See Why FDA Hit Red Light On Kura's Early-Stage Leukemia Trial
   
  November 24, 2021
  Tickers 
   KURA
  
  
  From Benzinga
 
   Aptevo Stock Rallies After Posting First Complete Remission In Early Acute Myeloid Leukemia Trial
   
  November 23, 2021
  Tickers 
   APVO
  
  
  From Benzinga
 
   AstraZeneca Pulls Plug On MCL-1 Cancer Drug Trial
   
  
  
  October 20, 2021
  From Benzinga
 
   GlycoMimetics' Lead Candidate Data Published In An Online Journal
   
  September 24, 2021
  Tickers 
   GLYC
  
  
  From Benzinga
 
   Intellia To Test CRISPR-Engineered TCR-T Cell Candidate In Acute Myeloid Leukemia Patients
   
  September 16, 2021
  Tickers 
   NTLA
  
  
  From Benzinga
 
   Magenta Therapeutics' Shares Gain As FDA Signs Off Blood Cancer Candidate To Enter Human Trial
   
  
  
  September 15, 2021
  From Benzinga
 
   Vor Biopharma's Lead Hematopoietic Stem Cell Candidate Fast Tracked In US
   
  September 09, 2021
  Tickers 
   VOR
  
  
  From Benzinga
 
   Why Bio-Path Shares Are Moving Higher In Premarket Tuesday?
   
  August 24, 2021
  Tickers 
   BPTH
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

